| Product Code: ETC7552096 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India prostacyclin market import shipments demonstrated robust growth from 2020 to 2024, with a notable CAGR of 11.7%. Momentum accelerated further between 2023 and 2024, showing a growth rate of 35.3%, indicating a significant expansion trend in recent years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Prostacyclin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Prostacyclin Market Revenues & Volume, 2021 & 2031F |
3.3 India Prostacyclin Market - Industry Life Cycle |
3.4 India Prostacyclin Market - Porter's Five Forces |
3.5 India Prostacyclin Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 India Prostacyclin Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 India Prostacyclin Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 India Prostacyclin Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 India Prostacyclin Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Prostacyclin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Prostacyclin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pulmonary arterial hypertension (PAH) in India |
4.2.2 Rising awareness about PAH and its treatment options |
4.2.3 Growing healthcare infrastructure and expenditure in India |
4.3 Market Restraints |
4.3.1 High cost associated with prostacyclin therapy |
4.3.2 Limited accessibility to specialized healthcare facilities in remote areas of India |
4.3.3 Stringent regulatory requirements for drug approval and commercialization in the country |
5 India Prostacyclin Market Trends |
6 India Prostacyclin Market, By Types |
6.1 India Prostacyclin Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 India Prostacyclin Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 India Prostacyclin Market Revenues & Volume, By Pulmonary Arterial Hypertension, 2021- 2031F |
6.1.4 India Prostacyclin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Prostacyclin Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 India Prostacyclin Market Revenues & Volume, By Epoprostenol, 2021- 2031F |
6.2.3 India Prostacyclin Market Revenues & Volume, By Treprostinil, 2021- 2031F |
6.2.4 India Prostacyclin Market Revenues & Volume, By Iloprost, 2021- 2031F |
6.3 India Prostacyclin Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 India Prostacyclin Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 India Prostacyclin Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 India Prostacyclin Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 India Prostacyclin Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Prostacyclin Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 India Prostacyclin Market Revenues & Volume, By Inhalations, 2021- 2031F |
6.5 India Prostacyclin Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Prostacyclin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Prostacyclin Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 India Prostacyclin Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6 India Prostacyclin Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Prostacyclin Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 India Prostacyclin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 India Prostacyclin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.5 India Prostacyclin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Prostacyclin Market Import-Export Trade Statistics |
7.1 India Prostacyclin Market Export to Major Countries |
7.2 India Prostacyclin Market Imports from Major Countries |
8 India Prostacyclin Market Key Performance Indicators |
8.1 Number of PAH diagnoses in India |
8.2 Adoption rate of prostacyclin therapy in PAH patients |
8.3 Number of healthcare facilities offering prostacyclin therapy in India |
9 India Prostacyclin Market - Opportunity Assessment |
9.1 India Prostacyclin Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 India Prostacyclin Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 India Prostacyclin Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 India Prostacyclin Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 India Prostacyclin Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Prostacyclin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Prostacyclin Market - Competitive Landscape |
10.1 India Prostacyclin Market Revenue Share, By Companies, 2024 |
10.2 India Prostacyclin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here